592 related articles for article (PubMed ID: 30820689)
1. Preparation and Evaluation of Irinotecan Poly(Lactic-co-Glycolic Acid) Nanoparticles for Enhanced Anti-tumor Therapy.
Yang X; Yang Y; Jia Q; Hao Y; Liu J; Huang G
AAPS PharmSciTech; 2019 Feb; 20(3):133. PubMed ID: 30820689
[TBL] [Abstract][Full Text] [Related]
2. Effect of metformin/irinotecan-loaded poly-lactic-co-glycolic acid nanoparticles on glioblastoma: in vitro and in vivo studies.
Taghizadehghalehjoughi A; Hacimuftuoglu A; Cetin M; Ugur AB; Galateanu B; Mezhuev Y; Okkay U; Taspinar N; Taspinar M; Uyanik A; Gundogdu B; Mohammadzadeh M; Nalci KA; Stivaktakis P; Tsatsakis A; Jung TW; Jeong JH; Abd El-Aty AM
Nanomedicine (Lond); 2018 Jul; 13(13):1595-1606. PubMed ID: 30028222
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral Injection Administration of Irinotecan-Loaded Microspheres: In Vitro and In Vivo Evaluation.
Zhu S; Dou M; Huang G
AAPS PharmSciTech; 2018 Nov; 19(8):3829-3838. PubMed ID: 30280351
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line.
Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M
Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
[TBL] [Abstract][Full Text] [Related]
6. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.
Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA
Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589
[TBL] [Abstract][Full Text] [Related]
7. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan.
Sepehri N; Rouhani H; Tavassolian F; Montazeri H; Khoshayand MR; Ghahremani MH; Ostad SN; Atyabi F; Dinarvand R
Int J Pharm; 2014 Aug; 471(1-2):485-97. PubMed ID: 24879937
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance.
Zhu H; Chen H; Zeng X; Wang Z; Zhang X; Wu Y; Gao Y; Zhang J; Liu K; Liu R; Cai L; Mei L; Feng SS
Biomaterials; 2014 Feb; 35(7):2391-400. PubMed ID: 24360574
[TBL] [Abstract][Full Text] [Related]
10. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA.
Nair K L; Jagadeeshan S; Nair SA; Kumar GS
Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233
[TBL] [Abstract][Full Text] [Related]
11. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations.
Ahmad N; Alam MA; Ahmad R; Umar S; Jalees Ahmad F
J Microencapsul; 2018 Jun; 35(4):327-343. PubMed ID: 29873288
[TBL] [Abstract][Full Text] [Related]
12. HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin.
Rani S; Gothwal A; Pandey PK; Chauhan DS; Pachouri PK; Gupta UD; Gupta U
Pharm Res; 2018 Dec; 36(1):19. PubMed ID: 30511238
[TBL] [Abstract][Full Text] [Related]
13. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
Song X; Wang J; Xu Y; Shao H; Gu J
Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
[TBL] [Abstract][Full Text] [Related]
14. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
15. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
Li JL; Zheng CL; Liu JP; Zhu JB
Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
[TBL] [Abstract][Full Text] [Related]
16. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro.
Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ
Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859
[TBL] [Abstract][Full Text] [Related]
17. Brigatinib loaded poly(d,l-lactide-co-glycolide) nanoparticles for improved anti-tumoral activity against non-small cell lung cancer cell lines.
Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Bhatia S; Al-Harrasi A
Drug Dev Ind Pharm; 2021 Jul; 47(7):1112-1120. PubMed ID: 34551665
[TBL] [Abstract][Full Text] [Related]
18. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
[TBL] [Abstract][Full Text] [Related]
19. Na
Araste F; Abnous K; Hashemi M; Dehshahri A; Detampel P; Alibolandi M; Ramezani M
Eur J Pharm Sci; 2020 Feb; 143():105207. PubMed ID: 31870814
[TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients.
Derakhshandeh K; Soheili M; Dadashzadeh S; Saghiri R
Int J Nanomedicine; 2010 Aug; 5():463-71. PubMed ID: 20957168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
